Mechanism of action of P-glycoprotein in relation to passive membrane permeation

International Review of Cytology

Volumn 190, Issue , 1999, Pages 175-250

  Eytan, Gera D ^a   Kuchel, Philip W ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ABC transporter; Flip flop; Multidrug resistance; P glycoprotein; Transmembrane movement

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CALCIUM; CYCLOSPORIN A; DAUNOMYCINONE; DILTIAZEM; DOXORUBICIN; GLYCOPROTEIN P; GRAMICIDIN; HOE 33342; MITOXANTRONE; ORGANIC SOLVENT; PACLITAXEL; PHOSPHOLIPID; PROGESTERONE; QUINIDINE; QUININE; RHODAMINE; TACROLIMUS; TRIFLUOPERAZINE; VALINOMYCIN; VERAPAMIL; VINBLASTINE;

ACTIVE TRANSPORT; BILAYER MEMBRANE; CALCIUM TRANSPORT; CELL KINETICS; CELL MEMBRANE; COMPUTER MODEL; CYTOPLASM; CYTOTOXICITY; DRUG ADSORPTION; DRUG BINDING; DRUG DIFFUSION; DRUG TRANSPORT; FLUORESCENCE ANALYSIS; GENE OVEREXPRESSION; HUMAN; HYDROPHOBICITY; ION TRANSPORT; MEMBRANE BIOLOGY; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SENSITIZATION; STOICHIOMETRY;

CINCHONA PUBESCENS;

EID: 0032956955     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0074-7696(08)62148-8     Document Type: Review

References (184)

1. al-Shawi, M. K., Urbatsch, I. L., and Senior, A. E. (1994). Covalent inhibitors of P-glycoprotein ATPase activity. /. Biol. Chem. 269, 8986-8992.
2. Ambudkar, S. V., Cardarelli, C. O., Pashinsky, I., and Stein, W. D. (1997). Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. J. Biol. Chem. 272, 21160-21166.
3. Ambudkar, S. V., Lelong, I. H., Zhang, J., Cardarelli, C. O., Gottesman, M. M., and Pastan, I. (1992). Partial purification and reconstitution of the human multidrug-resistance pump: Characterization of the drug-stimulatable ATP hydrolysis. Proc. Natl. Acad. Sci. USA 89, 8472-8476.
4. Arceci, R. J. (1993). Clinical significance of P-glycoprotein in mullidrug resistance malignancies. Blood 81, 2215-2222.
5. Arceci, R. J., Croop, J. M., Honvitz, S. B., and Housman, D. (1988). The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc. Natl. Acad. Sei. USA 85, 4350-4354.
6. Assaraf, Y. G., and Borgnia, M. J. (1994). Probing the interaction of the multidrug-resistance phenotype with the polypeptide ionophore gramicidin D via functional channel formation. Eur. J. Biochem. 222, 813-824.
7. Ayesh, S., Shao, Y. M., and Stein, W. D. (1996). Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein. Biochim. Biophys. Acta 1316, 8-18.
8. Bates, S. E., Wilson, W. H., Fojo, A. T., Alvarez, M., Zhan, Z., Regis, J., Robey, R., Hose, C., Monks, A., Kang, Y. K., and Chabner, B. (1996). Clinical reversal of multidrug resistance. Stem Cells 14, 56-63.
9. Beaudet, L., and Gros, P. (1995). Functional dissection of P-glycoprotein nucleotide-binding domains in chimeric and mutant proteins. Modulation of drug resistance profiles. J. Biol. Chem. 270, 17159-17170.
10. Beck, W. T., Grogan, T. M., Willman, C. L., Cordon-Cardo, C, Parham, D. M., Kuttesch, J. F., Andreeff, M., Bates, S. E., Berard, C. W., Boyett, J. M., Brophy, N. A., Broxterman, H. J., Chan, H. S., Dalton, W. S., Dietel, M., Fojo, A. T., Gascoyne, R. D., Head, D., Houghton, P. J., Srivastava, D. K., Lehnert, M., Leith, C. P., Paietta, E., Pavelic, Z. P., and Weinstein, R. (1996). Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations. Cancer Res. 56, 3010-3020.
11. Benz, R., and Lauger, P. (1976). Kinetic analysis of carrier-mediated ion transport by the charge-pulse technique. /. Membr. Biol. 27, 171-191.
12. Berthon, H. A., and Kuchel, P. W. (1995). NMR studies of erythrocyte metabolism. In "Advances in Molecular and Cell Biology," pp. 147-205. JAI Press, Greenwich, CT.
13. Bishop, L., Agbayani, R., Jr., Ambudkar, S. V., Maloney, P. C, and Ames, G. F. (1989). Reconstitution of a bacterial periplasmic permease in proteoliposomes and demonstration of ATP hydrolysis concomitant with transport. Proc. Natl. Acad. Sci. USA 86, 6953-6957.
14. Boesch, D., Gaveriaux, C., Jachez, B., Pourtier-Manzanedo, A., Bollinger, P., and Loor, F. (1991). In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833. Cancer Res. 51, 4226-4233.
15. Bolhuis, H., van Veen, H. W., Molenaar, D., Poolman, B., Driessen, A. J., and Konings, W. N. (1996). Multidrug resistance in Lactococcus lactis: Evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane. EMBO J. 15, 4239-4245.
16. Borgnia, M. J., Eytan, G. D., and Assaraf, Y. G. (1996). Competition of Hydrophobie peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. /. Biol. Chem. 271, 3163-3171.
17. Bornmann, W. G., and Roepe, P. D. (1994). Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound. Biochemistry 33,12665-12675.
18. Borrel, M. N., Pereira, E., Fiallo, M., and Garnier-Suillerot, A. (1994). Mobile ionophores are a novel class of P-glycoprotein inhibitors: The effects of ionophores on 4′-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells. Eur. J. Biochem. 223, 125-133.
19. Bradbury, M. W. (1985). The blood-brain barrier: Transport across the cerebral endothelium. Circ. Res. 57, 213-222.
20. Bradley, G., Juranka, P. F., and Ling, V. (1988). Mechanism of multidrug resistance. Biochim. Biophys. Acta 948, 87-128.
21. Burke, T. G., Israel, M., Seshadri, R., and Doroshow, J. H. (1990). Abrogation of the selectivity of adriamycin for negatively-charged phospholipids by 14-valerate side chain substitution. Cancer Biochem. Biophys. 11,177-185.
22. Burke, T. G., and Tritton, T. R. (1985). Structural basis of anthracycline selectivity for unilamellar phosphatidylcholine vesicles: An equilibrium binding study. Biochemistry 24,1768-1776.
23. Cano-Gauci, D. F., Busche, R., Tummler, B., and Riordan, J. R. (1990). Fast kinetic analysis of drug transport in multidrug resistant cells using a pulsed quench-flow apparatus. Biocliem. Biophys. Res. Commun. 167, 48-53.
24. Chabner, B. A., and Wilson, W. (1991). Reversal of multidrug resistance. /. Clin. Oncol. 9,4-6.
25. Chen, C. C, and Wilson, T. H. (1984). The phospholipid requirement for activity of the lactose carrier of Escherichia colt. J. Biol. Chem. 259,10150-10158.
26. Chen, G., Duran, G. E., Steger, K. A., Lacayo, N. J., Jaffrezou, J. P., Dumontet, C, and Sikic, B. I. (1997). Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. /. Biol. Chem. 272, 5974-5982.
27. Cole, S. P., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C, Stewart, A. J., Kurz, E. U., Duncan, A. M., and Deeley, R. G. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1654.
28. Cole, S. P., and Deeley, R. G. (1993). Multidrug resistance-associated protein: Sequence correction. Science 260, 879.
29. Cole, S. P., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., and Deeley, R. G. (1994). Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 54, 5902-5910.
30. Collander, R. (1954). The permeability of Nitella cells to nonelectrolytes. Physiol. Plant 7, 420-445.
31. Constantinides, P. P., Ghosaini, L., Inouchi, N., Kitamura, S., Seshadri, R., Israel, M., Sartorelli, A. C., and Sturtevant, J. M. (1989). Interaction of N-alkylanthracyclines with lipid bilayers: Correlations between partition coefficients, lipid phase distributions and thermotropic behavior. Chem. Phys. Lipids 51, 105-118.
32. Cordon-Cardo, C., O'Brien, J. P., Boccia, J., Casals, D., Bertino, J. R., and Melamed, M. R. (1990). Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38,1277-1287.
33. Cornwell, M. M., Pastan, I., and Gottesman, M. M. (1987). Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J. Biol. Chem. 262, 2166-2170.
34. Cornwell, M. M., Safa, A. R., Felsted, R. L., Gottesman, M. M., and Pastan, I. (1986). Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling. Proc. Nail Acad. Sci. USA 83, 3847-3850.
35. Currier, S. J., Kane, S. E., Willingham, M. C, Cardarelli, C. O., Pastan, I., and Gottesman, M. M. (1992). Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters. /. Biol. Chem. 267, 25153-25159.
36. Dalmark, M. (1981). Characteristics of doxorubicin transport in human red blood cells. Scand. ]. Clin. Lab. Invest. 41, 633-639.
37. Dalmark, M., and Hoffmann, E. K. (1983). Doxorubicin (Adriamycin) transport in Ehrlich ascites tumour cells: comparison with transport in human red blood cells. Scand. J. Clin. Lab. Invest. 43, 241-248.
38. Dano, K. (1971). Development of resistance to daunomycin (NSC-82151) in Ehrlich ascites tumor. Cancer Chemolher. Rep. 55, 133-141.
39. Demant, E. J., Sehested, M., and Jensen, P. B. (1990). A model for computer simulation of P-glycoprotein and transmembrane delta pH-mediated anthracycline transport in multidrug-resistant tumor cells. Biochim. Biophys. Acta 1055, 117-125.
40. Devault, A., and Gros, P. (1990). Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol. Cell. Biol. 10, 1652-1663.
41. de Wolf, F. A., Demel, R. A., Bets, D., van Kats, C., and de Kruijff, B. (1991). Characterization of the interaction of doxorubicin with (poly)phosphoinositides in model systems: Evidence for specific interaction with phosphatidylinositol-monophosphate and -diphosphate. FEBS Lett 288, 237-240.
42. de Wolf, F. A., Nicolay, K., and de Kruijff, B. (1992). Effect of doxorubicin on the order of the acyl chains of anionic and zwitterionic phospholipids in liquid-crystalline mixed model membranes: Absence of drug-induced segregation of lipids into extended domains. Biochemistry 31, 9252-9262.
43. de Wolf, F. A., Staffhorst, R. W., Smits, H. P., Onwezen, M. F., and de Kruijff, B. (1993). Role of anionic phospholipids in the interaction of doxorubicin and plasma membrane vesicles: Drug binding and structural consequences in bacterial systems. Biochemistry 32, 6688-6695.
44. Dhir, R., Grizzuti, K., Kajiji, S., and Gros, P. (1993). Modulatory effects on substrate specificity of independent mutations at the serine939/941 position in predicted transmembrane domain 11 of P-glycoproteins. Biochemistry 32, 9492-9499.
45. Doige, C. A., and Sharom, F. J. (1992). Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta 1109,161-171.
46. Doige, C. A., Yu, X., and Sharom, F. J. (1993). The effects of lipids and detergents on ATPase-active P-glycoprotein. Biochim. Biophys. Acta 1146, 65-72.
47. Dordal, M. S., Winter, J. N., and Atkinson, A. J., Jr. (1992). Kinetic analysis of P-glycoprotein-mediated doxorubicin efflux. /. Pharmacol. Exp. Ther. 263, 762-766.
48. Drori, S., Eytan, G. D., and Assaraf, Y. G. (1995). Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur. J. Biochem. 228, 1020-1029.
49. Dudeja, P. K., Anderson, K. M., Harris, J. S., Buckingham, L., and Coon, J. S. (1995). Reversal of multidrug resistance phenotype by surfactants: Relationship to membrane lipid fluidity. Arch. Biochem. Biophys 319, 309-315.
50. DuPre, A. M., and Hempling, H. G. (1978). Osmotic properties of Ehrlich ascites tumor cells during the cell cycle. /. Cell Physiol. 97, 381-396.
51. Eytan, G. D., Borgnia, M. J., Regev, R., and Assaraf, Y. G. (1994). Transport of polypeptide ionophores into proteoliposomes reconstituted with rat liver P-glycoprotein. /. BioL Chem. 269, 26058-26065.
52. Eytan, G. D., Regev, R., and Assaraf, Y. G. (1996a). Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis. /. Biol. Chem. 271, 3172-3178.
53. Eytan, G. D., Regev, R., Oren, G., and Assaraf, Y. G. (1996b). The role of passive transbilayer drug movement in multidrug resistance and its modulation. /. Biol. Chem. 271,12897-12902.
54. Ferry, D. R., Russell, M. A., and Cullen, M. H. (1992). P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site. Biochem. Biophys. Res. Commun 188, 440-445.
55. Fisher, G. A., and Sikic, B. I. (1995). Clinical studies with modulators of multidrug resistance. Hematol. Oncol. Clin. North Am. 9, 363-382.
56. Foxwell, B. M., Mackie, A., Ling, V., and Ryffel, B. (1989). Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein. Mol. Pharmacol. 36, 543-546.
57. Frezard, F., and Garnier-Suillerot, A. (1991). Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells. Eur. J. Biochem. 196, 483-491.
58. Frezard, F., and Garnier-Suillerot, A. (1998). Permeability of lipid bilayer to anthracycline derivatives: Role of the bilayer composition and of the temperature. Biochim. Biophys. Acta 1389,13-22.
59. Friche, E., Jensen, P. B., Sehested, M., Demant, E. J., and Nissen, N. N. (1990). The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun. 2, 297-303.
60. Gallois, L., Fiallo, M., and Garnier-Suillerot, A. (1998). Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles: Circular dichroism study. Biochim. Biophys. Acta 1370, 31-40.
61. Garfinkel, D. (1966). A simulation study of the metabolism and compartmentation in brain of glutamate, aspartate, the Krebs cycle, and related metabolites. J. Biol. Chem. 241,3918-3929.
62. Garrigos, M., Belehradek, J., Jr., Mir, L. M., and Orlowski, S. (1993). Absence of cooperativity for MgATP and verapamil effects on the ATPase activity of P-glycoprotein containing membrane vesicles. Biochem, Biophys. Res. Commun. 196,1034-1041.
63. Gasset, M., Killian, J. A., Tournois, H., and de Kruijff, B. (1988). Influence of cholesterol on gramicidin-induced HII phase formation in phosphatidylcholine model membranes. Biochim. Biophys. Acta 939, 79-88.
64. Ghauharali, R. L, Westerhoff, H. V., Dekker, H., and Lankelma, J. (1996). Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB8-5 cells. Biochim. Biophys. Acta 1278, 213-222.
65. Gottesman, M. M., and Pastan, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427.
66. Gros, P., Ben Neriah, Y. B., Croop, J. M., and Housman, D. E. (1986). Isolation and expression of a complementary DNA that confers multidrug resistance. Nature 323, 728-731.
67. Gros, P., Dhir, R., Croop, J., and Talbot, F. (1991). A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdrl and mdr3 drug efflux pumps. Proc. Natl. Acad. Sci. USA 88, 7289-7293.
68. Haest, C. W., Oslender, A., and Kamp, D. (1997). Nonmediated flip-flop of anionic phospholipids and long-chain amphiphiles in the erythrocyte membrane depends on membrane potential. Biochemistry 36, 10885-10891.
69. Hearon, J. Z. (1953). The kinetics of linear systems with special reference to periodic vectors. Bull. Math. Biophys. 15, 121-141.
70. Hedley, D. W., Xie, S. X., Minden, M. D., Choi, C. H., Chen, H., and Ling, V. (1997). A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia. Leukemia 11, 48-53.
71. Higgins, C. F. (1992). ABC transporters: From microorganisms to man. Annu. Rev. Cell Biol. 8, 67-113.
72. Higgins, C. F., Callaghan, R., Linton, K. J., Rosenberg, M. F., and Ford, R. C. (1997). Structure of the multidrug resistance P-glycoprotein. Semin. Cancer Biol. 8, 135-142.
73. Higgins, C. F., and Gottesman, M. M. (1992). Is the multidrug transporter a flippase? Trends Biochem. Sci. 17, 18-21.
74. Hollo, Z., Homolya, L., Davis, C. W., and Sarkadi, B. (1994). Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim. Biophys. Acta 1191, 384-388.
75. Homolya, L., Hollo, Z., Germann, U. A., Pastan, I., Gottesman, M. M., and Sarkadi, B. (1993). Fluorescent cellular indicators are extruded by the multidrug resistance protein. /. Biol. Chem. 268, 21493-21496.
76. Horio, M., Gottesman, M. M., and Pastan, I. (1988). ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. Natl. Acad. Sci. USA 85,3580-3584.
77. 3H] vinblastine transport by isolated vesicles. Biochim. Biophys. Acta 1061, 106-110.
78. Horio, M., Pastan, I., Gottesman, M. M., and Handler, J. S. (1990). Transepithelial transport of vinblastine by kidney-derived cell lines: Application of a new kinetic model to estimate in situ Km of the pump. Biochim. Biophys. Acta 1027, 116-122.
79. Inaba, M., Kobayashi, H., Sakurai, Y., and Johnson, R. K. (1979). Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res. 39, 2200-2203.
80. Israel, M., Seshadri, R., Koseki, Y., Sweatman, T. W., and Idriss, J. M. (1987). Amelioration of adriamycin toxicity through modification of drug-DNA binding properties. Cancer Treat. Rev. 14, 163-167.
81. Kajiji, S., Dreslin, J. A., Grizzuti, K., and Gros, P. (1994). Structurally distinct MDR modulators show specific patterns of reversal against P-glycoproteins bearing unique mutations at serine939/941. Biochemistry 33, 5041-5048.
82. Kaye, S. B. (1995). Clinical drug resistance: The role of factors other than P-glycoprotein. Am. J. Med. 99, 40S-44S.
83. Kolaczkowski, M., van der Rest, M., Cybularz-Kolaczkowska, A., Soumillion, J. P., Konings, W. N., and Goffeau, A. (1996). Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J. Biol. Chem. 271, 31543-31548.
84. Krishnamachary, N., and Center, M. S. (1993). The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res. 53, 3658-3661.
85. Kuchel, P. W. (1985). Kinetic analysis of multienzyme systems in homogeneous solution. In "Organised Multienzyme Systems" (G. R. Welch, ed.), pp. 303-380. Academic Press, New York.
86. Kuchel, P. W., and Chapman, B. E. (1983). NMR spin exchange kinetics at equilibrium in membrane transport and enzyme systems. J. Theor. Biol. 105, 569-589.
87. Kuchel, P. W., and Ralston, G. B. (1997). "Outline of Theory and Problems of Biochemistry." McGraw-Hill, New York.
88. Kuchel, P. W., Roberts, D. V., and Nichol, L. W. (1977). The simulation of the urea cycle: correlation of effects due to inborn errors in the catalytic properties of the enzymes with clinical-biochemical observations. Aust. J. Exp. Biol. Med. Sci. 55, 309-326.
89. Lam, C. F. (1981). "Techniques for Analysis and Modelling of Enzyme Kinetic Mechanisms." Research Studies Press, Chichester.
90. Lieb, W. R., and Stein, W. D. (1986). Non-Stokesian nature of transverse diffusion within human red cell membranes. J. Membr. Biol. 92,111-119.
91. Lincke, C. R., van der Bliek, A. M., Schuurhuis, G. J., van der Velde-Koerts, T., Smit, J. J., and Borst, P. (1990). Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdrl complementary DNA. Cancer Res. 50,1779-1785.
92. Ling, V. (1992). Charles F. Kettering Prize: P-glycoprotein and resistance to anticancer drugs. Cancer 69, 2603-2609.
93. Ling, V. (1995). P-glycoprotein: Its role in drug resistance. Am. J. Med. 99, 31S-34S.
94. List, A. F., Spier, C. S., Grogan, T. M., Johnson, C., Roe, D. J., Greer, J. P., Wolff, S. N., Broxterman, H. J., Scheffer, G. L., Scheper, R. J., and Dalton, W. S. (1996). Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 87, 2464-2469.
95. Litman, T., Zeuthen, T., Skovsgaard, T., and Stein, W. D. (1997). Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its AT-Pase activity. Biochim. Biophys. Ada 1361, 169-176.
96. Loe, D. W., and Sharom, F. J. (1993). Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles. Br. J. Cancer 68, 342-351.
97. Loe, D. W., and Sharom, F. J. (1994). Interaction of multidrug-resistant Chinese hamster ovary cells with the peptide ionophore gramicidin D. Biochim. Biophys. Acta 1190,72-84.
98. Marks, D. C, Su, G. M., Davey, R. A., and Davey, M. W. (1996). Extended multidrug resistance in haemopoietic cells. Br. J. Haematol 95, 587-595.
99. Martin, C, Berridge, G., Higgins, C. F., and Callaghan, R. (1997). The multi-drug resistance reversal agent SR33557 and modulation of vinca alkaloid binding to P-glycoprotein by an allosteric interaction. Br. J. Pharmacol 122, 765-771.
100. McNamee, M. G., and McConnell, H. M. (1973). Transmembrane potentials and phospholipid flip-flop in excitable membrane vesicles. Biochemistry 12, 2951-2958.
101. Mimmack, M. L., Gallagher, M. P., Pearce, S. R., Hyde, S. C, Booth, I. R., and Higgins, C. F. (1989). Energy coupling to periplasmic binding protein-dependent transport systems: Stoichiometry of ATP hydrolysis during transport in vivo. Proc. Natl. Acad. Sei. USA 86, 8257-8261.
102. Moore, W. J. (1981). "Physical Chemistry." Longman, NJ.
103. Nicolay, K., Timmers, R. J., Spoelstra, E., Van der Neut, R., Fok, J. J., Huigen, Y. M., Verkleij, A. J., and De Kruijff, B. (1984). The interaction of adriamycin with cardiolipin in model and rat liver mitochondria! membranes. Biochim. Biophys. Acta 778, 359-371.
104. Nielsen, D., Maare, C., and Skovsgaard, T. (1994). Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein. Biochem. Pharmacol. 47, 2125-2135.
105. O'Connell, A. M., Koeppe, R. E. D., and Andersen, O. S. (1990). Kinetics of gramicidin channel formation in lipid bilayers: Transmembrane monomer association. Science 250,1256-1259.
106. Orlowski, S., Mir, L. M., Belehradek, J., Jr., and Garrigos, M. (1996). Effects of steroids and verapamil on P-glycoprotein ATPase activity: Progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem. J. 317, 515-522.
107. Qian, X. D., and Beck, W. T. (1990). Binding of an optically pure photoafflnity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines. Cancer Res. 50, 1132-1137.
108. Ramu, A., Glaubiger, D., and Fuks, Z. (1984). Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. Cancer Res. 44, 4392-4395.
109. Ramu, A., Pollard, H. B., and Rosario, L. M. (1989). Doxorubicin resistance in P388 leukemia: Evidence for reduced drug influx. Int. J. Cancer 44, 539-547.
110. Raviv, Y., Pollard, H. B., Bruggemann, E. P., Pastan, I., and Gottesman, M. M. (1990). Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. J. Biol. Chem. 265, 3975-3980.
111. Regev, R., and Eytan, G. D. (1997). Flip-flop of doxorubicin across erythrocyte and lipid membranes. Biochem. Pharmacol. 54, 1151-1158.
112. Riehm, H., and Biedler, J. L. (1972). Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin. Cancer Res. 32, 1195-1200.
113. Roberts, D. V. (1977). "Enzyme Kinetics." Cambridge Univ. Press, Cambridge, UK.
114. Roepe, P. D., Wei, L. Y., Cruz, J., and Carlson, D. (1993). Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: Further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochemistry 32,11042-11056.
115. Roninson, I. B., Abelson, H. T., Housman, D. E., Howell, N., and Varshavsky, A. (1984). Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells. Nature 309, 626-628.
116. Ross, D. D., Woolen, P. J., Tong, Y., Comblait, B., Levy, C, Sridhara, R., Lee, E. J., and Schiffer, C. A. (1994). Synergistic reversal of mullidrug-resislance phenolype in acute myeloid leukemia cells by cyclosporin A and cremophor EL. Blood 83,1337-1347.
117. Rolhman, J. E., and Dawidowicz, E. A. (1975). Asymmelric exchange of vesicle phospholipids calalyzed by the phosphatidylcholine exchange protein: Measurement of inside-oulside transitions. Biochemistry 14, 2809-2816.
118. Sabeur, G., Genest, D., and Aubel-Sadron, G. (1979). Interaclion belween daunorubicin and chromalin from Ehrlich asciles tumor cells. Biochem. Biophys. Res. Commun. 88,722-729.
119. Saeki, T., Shimabuku, A. M., Ueda, K., and Komano, T. (1992). Specific drug binding by purified lipid-reconstiluled P-glycoprolein: Dependence on the lipid composilion. Biochim. Biophys. Acta 1107,105-110.
120. Saeki, T., Ueda, K., Tanigawara, Y., Hori, R., and Komano, T. (1993). P-glycoprotein-mediated transcellular transport of MDR-reversing agents. FEES Lett. 324, 99-102.
121. Safa, A. R., Glover, C. J., Meyers, M. B., Biedler, J. L., and Felsted, R. L. (1986). Vinblastine photoaffmity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J. Biol. Chem. 261, 6137-6140.
122. Sarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A., and Scarborough, G. A. (1992). Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267, 4854-4858.
123. Scala, S., Akhmed, N., Rao, U. S., Paull, K., Lan, L. B., Dickstein, B., Lee, J. S., Elgemeie, G. H., Stein, W. D., and Bates, S. E. (1997). P-glycoprotein substrates and antagonists cluster into two distinct groups. Mol. Pharmacol. 51,1024-1033.
124. Scheper, R. J., Broxterman, H. J., Scheffer, G. L., Kaaijk, P., Dalton, W. S., van Heijningen, T. H., van Kalken, C. K., Slovak, M. L., de Vries, E. G., van der Valk, P., et al. (1993). Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res. 53, 1475-1479.
125. Schinkel, A. H. (1998). Pharmacological insights from P-glycoprotein knockout mice. Int. J. Clin. Pharmacol. Ther. 36, 9-13.
126. Schinkel, A. H., Smit, J. J., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P., et al. (1994). Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
127. Schlemmer, S. R., and Sirotnak, F. M. (1994). Functional studies of P-glycoprotein in insideout plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3: Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport [published erratum appears in J. Biol. Chem. 270(7), 3462 1995.
128. Schwartz, M. A., and McConnell, H. M. (1978). Surface areas of lipid membranes. Biochemistry 17, 837-840.
129. Sehested, M., Skovsgaard, T., van Deurs, B., and Winther-Nielsen, H. (1987). Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil. Br. J. Cancer 56, 747-751.
130. Senior, A. E., and Bhagat, S. (1998). P-glycoprotein shows strong catalytic cooperativity between the two nucleotide sites. Biochemistry 37, 831-836.
131. Shalinsky, D. R., Jekunen, A. P., Alcaraz, J. E., Christen, R. D., Kim, S., Khatibi, S., and Howell, S. B. (1993). Regulation of initial vinblastine influx by P-glycoprotein. Br. J. Cancer 67, 30-36.
132. Shao, Y. M., Ayesh, S., and Stein, W. D. (1997). Mutually co-operative interactions between modulators of P-glycoprotein. Biochim. Biophys. Acta 1360, 30-38.
133. Shapiro, A. B., and Ling, V. (1994). ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J. Biol. Client. 269, 3745-3754.
134. Shapiro, A. B., and Ling, V. (1995). Reconstitution of drug transport by purified P-glycoprotein. J. Biol. Chem. 270,16167-16175.
135. Shapiro, A. B., and Ling, V. (1997). Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250, 130-137.
136. Sharom, F. J. (1995). Characterization and functional reconstitution of the multidrug transporter. J. Bioenerg. Biomembr. 27, 15-22.
137. Sharom, F. J., Yu, X., and Doige, C. A. (1993). Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem. 268, 24197-24202.
138. Sikic, B. I. (1997). Pharmacologie approaches to reversing multidrug resistance. Semin. Hematol. 34, 40-47.
139. Sikic, B. L, Fisher, G. A., Lum, B. L., Halsey, J., Beketic-Oreskovic, L., and Chen, G. (1997). Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother. Pharmacol. 40,(Suppl.), S13-S19.
140. Simon, S. M., and Schindler, M. (1994). Cell biological mechanisms of multidrug resistance in tumors. Proc. Natl. Acad. Sei. USA 91, 3497-3504.
141. Sinicrope, F. A., Dudeja, P. K., Bissonnette, B. M., Safa, A. R., and Brasitus, T. A. (1992). Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. J. Biol. Client. 267, 24995-25002.
142. Sirotnak, F. M., Yang, C. H., Mines, L. S., Oribe, E., and Biedler, J. L. (1986). Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids. J. Cell Physiol 126,266-274.
143. Skovsgaard, T. (1978). Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells. Cancer Res. 38, 1785-1791.
144. Skovsgaard, T. (1980). Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumor. Cancer Res. 40,1077-1083.
145. Slovak, M. L., Hoeltge, G. A., Dalton, W. S., and Trent, J. M. (1988). Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Cancer Res. 48, 2793-2797.
146. Speelmans, G., Staffhorst, R. W., de Kruijff, B., and de Wolf, F. A. (1994). Transport studies of doxorubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plasma membrane. Biochemistry 33,13761-13768.
147. Spoelstra, E. C, Dekker, H., Schuurhuis, G. J., Broxterman, H. J., and Lankelma, J. (1991). P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines: Evidence for a saturation of active daunorubicin transport. Biochem. Pharmacol. 41, 349-359.
148. Spoelstra, E. C., Westerhoff, H. V., Dekker, H., and Lankelma, J. (1992). Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells. Eur. J. Biochem. 207, 567-579.
149. Stein, W. (1986). "Transport and Diffusion across Cell Membranes." Academic Press, Orlando, FL.
150. Stein, W. (1990). "Channels, Carriers, and Pumps: An Introduction to Membrane Transport." Academic Press, San Diego.
151. Stein, W. D. (1997). Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol. Rev. 77, 545-590.
152. Stein, W. D., Cardarelli, C, Pastan, I., and Gottesman, M. M. (1994). Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. Mol. Pharmacol. 45, 763-772.
153. Sugawara, I., Kataoka, I., Morishita, Y., Hamada, H., Tsuruo, T., Itoyama, S., and Mon, S. (1988). Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res. 48,1926-1929.
154. Syed, S. K., Christopherson, R. I., and Roufogalis, B. D. (1993). Vinblastine transport by membrane vesicles from human multidrug-resistant CCRF-CEM leukaemia cells: Inhibition by taxol and membrane permeabilising agents. Biochem. Mol. Biol. Int. 30, 743-753.
155. Tamai, I., and Safa, A. R. (1991). Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. J. Biol. Chein. 266, 16796-16800.
156. Tarasiuk, J., Frezard, F., Garnier-Suillerot, A., and Gattegno, L. (1989). Anthracycline incorporation in human lymphocytes: Kinetics of uptake and nuclear concentration. Biocliim. Biophys. Acta 1013, 109-117.
157. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., and Willingham, M. C. (1987). Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sei. USA 84, 7735-7738.
158. Todd, A. P., Mehlhorn, R. J., and Macey, R. I. (1989). Amine and carboxylate spin probe permeability in red cells. J. Membr. Biol. 109, 41-52.
159. Tsien, R. Y. (1983). Intracellular measurements of ion activities. Annu. Rev. Biophys. Bioeng. 12, 91-116.
160. Tsuruo, T., lida, H., Kitatani, Y., Yokota, K., Tsukagoshi, S., and Sakurai, Y. (1984). Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res 44, 4303-4307.
161. Tsuruo, T., lida, H., Tsukagoshi, S., and Sakurai, Y. (1981). Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41, 1967-1972.
162. Tsuruo, T., lida, H., Tsukagoshi, S., and Sakurai, Y. (1982). Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 42, 4730-4733.
163. Twentyman, P. R. (1988). A possible role for cyclosporins in cancer chemotherapy. Anticancer Res. 8, 985-993.
164. Ueda, K., Cornwell, M. M., Gottesman, M. M, Pastan, I., Roninson, I. B., Ling, V., and Riordan, J. R. (1986). The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem. Biophys. Res. Commun. 141, 956-962.
165. Ueda, K., Taguchi, Y., and Morishima, M. (1997). How does P-glycoprotein recognize its substrates? Semin. Cancer Biol. 8, 151-159.
166. Urbatsch, I. L., al-Shawi, M. K., and Senior, A. E. (1994). Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. Biochemistry 33, 7069-7076.
167. Urbatsch, I. L., Beaudet, L., Carrier, I., and Gros, P. (1998). Mutations in either nudeotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites. Biochemistry 37, 4592-4602.
168. Urbatsch, I. L., Sankaran, B., Bhagat, S., and Senior, A. E. (1995). Both P-glycoprotein nucleotide-binding sites are catalytically active. J. Biol. Chem. 270, 26956-26961.
169. Urbatsch, I. L., and Senior, A. E. (1995). Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein. Arch. Biochem. Biophys. 316, 135-140.
170. Urry, D. W. (1971). The gramicidin A transmembrane channel: A proposed pi(L,D) helix. Proc. Natl. Acad. Sci. USA 68, 672-676.
171. Urry, D. W., Goodall, M. C, Glickson, J. D., and Mayers, D. F. (1971). The gramicidin A transmembrane channel: Characteristics of head-to-head dimerized (L,D) helices. Proc. Natl. Acad. Sci. USA 68, 1907-1911.
172. Wadkins, R. M., and Houghton, P. J. (1993). The role of drug-lipid interactions in the biological activity of modulators of multi-drug resistance. Biochim. Biophys. Acta 1153, 225-236.
173. Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982). Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1, 945-951.
174. Walter, A., and Gutknecht, J. (1986). Permeability of small nonelectrolytes through lipid bilayer membranes. J. Membr. Biol. 90, 207-217.
175. Weaver, J. L., Szabo, G., Jr., Pine, P. S., Gottesman, M. M., Goldenberg, S., and Aszalos, A. (1993). The effect of ion channel blockers, immunosuppressive agents, and other drugs on the activity of the multi-drug transporter. Int. J. Cancer 54, 456-461.
176. Wegscheider, R. (1901). Uber Simultane Gleichgewichte und die Beziehungen zwichen Thermodinamik und Reaktionkinetik. Z. Phisik. Chem. 39, 257-303.
177. Wimley, W. C., and Thompson, T. E. (1990). Exchange and flip-flop of dimyristoylphosphatidylcholine in liquid-crystalline, gel, and two-component, two-phase large unilamellar vesicles [published erratum appears in Biochemistry 29(19), 4746 (1990)]. Biochemistry 29, 1296-1303.
178. Wimley, W. C., and Thompson, T. E. (1991). Transbilayer and interbilayer phospholipid exchange in dimyristoylphosphatidylcholine/dimyristoylphosphatidylethanolamine large unilamellar vesicles. Biochemistry 30, 1702-1709.
179. Wolfram, S. (1996). "Mathematica, a System for Doing Mathematics by Computer," Version 3. Redwood City, CA.
180. Woodcock, D. M., Linsenmeyer, M. E., Chojnowski, G., Kriegler, A. B., Nink, V., Webster, L. K., and Sawyer, W. H. (1992). Reversal of multidrug resistance by surfactants. Br. J. Cancer 66, 62-68.
181. Xiang, T. X., and Anderson, B. D. (1994). The relationship between permeant size and permeability in lipid bilayer membranes. J. Membr. Biol. 140, 111-122.
182. Yang, C. P., Cohen, D., Greenberger, L. M., Hsu, S. I., and Horwitz, S. B. (1990). Differential transport properties of two mdr gene products are distinguished by progesterone. J. Biol. Chem. 265, 10282-10288.
183. Zamora, J. M., Pearce, H. L., and Beck, W. T. (1988). Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells. Mol. Pharmacol. 33, 454-462.
184. Zordan-Nudo, T., Ling, V., Liu, Z., and Georges, E. (1993). Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. Cancer Res. 53,5994-6000.